Kailera Therapeutics, Inc. (KLRA) Stock

Kailera Therapeutics, Inc. (KLRA) is a Healthcare stock trading at $17.46 (as of 2026-07-27), with a market capitalization of $2.29B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$17.46
Market Cap$2.29B
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$0.00
Financial Health — source: SEC EDGAR
Altman Z-Score0.70 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.2
Industry P/E (Pharmaceutical Products)17.0
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Trevi Therapeutics, Inc. (TRVI)
  • Nurix Therapeutics, Inc. (NRIX)
  • Nektar Therapeutics (NKTR)
  • Prestige Consumer Healthcare Inc. (PBH)
  • Nuvation Bio Inc. (NUVB)
  • Mineralys Therapeutics, Inc. (MLYS)
  • Agios Pharmaceuticals, Inc. (AGIO)
  • Biohaven Ltd. (BHVN)
KLRA earnings history · KLRA institutional & insider holders · KLRA KPIs & operating metrics · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-27.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.